Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis

Kien Chai Ong1, Munisamy Badmanathan, Shamala Devi

  • 1Department of Pathology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Insights

A new mouse model mimics human Enterovirus 71 encephalomyelitis, showing viral spread from muscle to the central nervous system (CNS). This model aids research into EV-A71 pathogenesis and potential therapies.

Area of Science:

  • Virology
  • Neuroscience
  • Pathology

Background:

  • Enterovirus 71 (EV-A71) causes severe neurological disease, including encephalomyelitis, particularly in children.
  • Existing animal models do not fully recapitulate the human central nervous system (CNS) pathology of EV-A71 infection.

Purpose of the Study:

  • To develop and characterize a novel mouse model of EV-A71 encephalomyelitis.
  • To investigate the viral distribution and spread within the CNS and peripheral tissues in this model.

Main Methods:

  • Infection of 2-week-old mice with a murine-adapted EV-A71 strain via oral and parenteral routes.
  • Analysis of viral RNA, antigens, and virions in CNS and peripheral tissues using in situ hybridization, immunohistochemistry, and electron microscopy.
  • Assessment of viral distribution and temporal progression of infection.

Main Results:

  • Mice developed fatal encephalomyelitis within 2-5 days post-infection.
  • Infected neurons were primarily located in the anterior horns, motor trigeminal nuclei, and brainstem reticular formation, with minimal inflammation.
  • Viral RNA and antigens were detected in skeletal muscle and peripheral motor nerves, suggesting entry into the CNS via these pathways.

Conclusions:

  • This mouse model accurately replicates key features of human EV-A71 encephalomyelitis.
  • The model demonstrates a distinct viral tropism, entering the CNS via peripheral motor nerves and spreading through neural pathways.
  • This model provides a valuable tool for studying EV-A71 pathogenesis and evaluating therapeutic interventions.